New TNF-α releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen

Hirota Fujiki, Masami Suganuma, Miki Kurusu, Sachiko Okabe, Yoko Imayoshi, Shoko Taniguchi, Takashi Yoshida

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Herbal medicines are now attracting attention as potential sources of cancer preventive agents. Using inhibition of tumor necrosis factor-α (TNF-α) release assay, we studied Acer nikoense, Megusurino-ki in Japanese. Inhibitory potential was found in the leaf extract, and the main active principles were identified as geraniin and corilagin. The IC50 values for TNF-α release inhibition were 43μM for geraniin and 76μM for corilagin, whereas that for (-)-epigallocatechin gallate (EGCG), the green tea polyphenol, as control was 26μM. Furthermore, treatment with geraniin inhibited okadaic acid tumor promotion in a two-stage carcinogenesis experiment on mouse skin. Geraniin and corilagin are present in another well-known Japanese traditional herb, Geranium thunbergii, Genno-shoko in Japanese. Considering seasonal variations of the agents and sites of cultivation of herbs, this paper reviews the significance of geraniin as a new cancer preventive agent. In addition, based on accumulated results of green tea as a cancer preventive, we review two important results with EGCG: the synergistic effects of EGCG with sulindac or tamoxifen on cancer preventive activity in PC-9 cells, and cancer prevention of intestinal tumor development in multiple intestinal neoplasia (Min) mice by cotreatment using EGCG with sulindac. We report here new findings on additional gene expression resulting from cotreatment with EGCG and sulindac in PC-9 cells compared with gene expression by EGCG alone or sulindac alone. Overall, our results indicate that, with the continuing spread of cancer chemoprevention as a fundamental medical strategy, both clinicians and researchers should take a closer look at herbal medicine.

Original languageEnglish
Pages (from-to)119-125
Number of pages7
JournalMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Volume523-524
DOIs
Publication statusPublished - Feb 2003

Fingerprint

Sulindac
Herbal Medicine
Traditional Medicine
Tamoxifen
Tumor Necrosis Factor-alpha
Neoplasms
Tea
Geranium
Acer
Intestinal Neoplasms
Gene Expression
Okadaic Acid
epigallocatechin gallate
Chemoprevention
Polyphenols
Inhibitory Concentration 50
Carcinogenesis
Research Personnel
Geraniin
Skin

Keywords

  • EGCG
  • Sulindac
  • Tamoxifen
  • TNF-α releasing inhibitors

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Molecular Biology

Cite this

New TNF-α releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen. / Fujiki, Hirota; Suganuma, Masami; Kurusu, Miki; Okabe, Sachiko; Imayoshi, Yoko; Taniguchi, Shoko; Yoshida, Takashi.

In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 523-524, 02.2003, p. 119-125.

Research output: Contribution to journalArticle

@article{1deefa8fa17e490d93d5df1e593b3a07,
title = "New TNF-α releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen",
abstract = "Herbal medicines are now attracting attention as potential sources of cancer preventive agents. Using inhibition of tumor necrosis factor-α (TNF-α) release assay, we studied Acer nikoense, Megusurino-ki in Japanese. Inhibitory potential was found in the leaf extract, and the main active principles were identified as geraniin and corilagin. The IC50 values for TNF-α release inhibition were 43μM for geraniin and 76μM for corilagin, whereas that for (-)-epigallocatechin gallate (EGCG), the green tea polyphenol, as control was 26μM. Furthermore, treatment with geraniin inhibited okadaic acid tumor promotion in a two-stage carcinogenesis experiment on mouse skin. Geraniin and corilagin are present in another well-known Japanese traditional herb, Geranium thunbergii, Genno-shoko in Japanese. Considering seasonal variations of the agents and sites of cultivation of herbs, this paper reviews the significance of geraniin as a new cancer preventive agent. In addition, based on accumulated results of green tea as a cancer preventive, we review two important results with EGCG: the synergistic effects of EGCG with sulindac or tamoxifen on cancer preventive activity in PC-9 cells, and cancer prevention of intestinal tumor development in multiple intestinal neoplasia (Min) mice by cotreatment using EGCG with sulindac. We report here new findings on additional gene expression resulting from cotreatment with EGCG and sulindac in PC-9 cells compared with gene expression by EGCG alone or sulindac alone. Overall, our results indicate that, with the continuing spread of cancer chemoprevention as a fundamental medical strategy, both clinicians and researchers should take a closer look at herbal medicine.",
keywords = "EGCG, Sulindac, Tamoxifen, TNF-α releasing inhibitors",
author = "Hirota Fujiki and Masami Suganuma and Miki Kurusu and Sachiko Okabe and Yoko Imayoshi and Shoko Taniguchi and Takashi Yoshida",
year = "2003",
month = "2",
doi = "10.1016/S0027-5107(02)00327-5",
language = "English",
volume = "523-524",
pages = "119--125",
journal = "Mutation Research",
issn = "0027-5107",
publisher = "Elsevier",

}

TY - JOUR

T1 - New TNF-α releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen

AU - Fujiki, Hirota

AU - Suganuma, Masami

AU - Kurusu, Miki

AU - Okabe, Sachiko

AU - Imayoshi, Yoko

AU - Taniguchi, Shoko

AU - Yoshida, Takashi

PY - 2003/2

Y1 - 2003/2

N2 - Herbal medicines are now attracting attention as potential sources of cancer preventive agents. Using inhibition of tumor necrosis factor-α (TNF-α) release assay, we studied Acer nikoense, Megusurino-ki in Japanese. Inhibitory potential was found in the leaf extract, and the main active principles were identified as geraniin and corilagin. The IC50 values for TNF-α release inhibition were 43μM for geraniin and 76μM for corilagin, whereas that for (-)-epigallocatechin gallate (EGCG), the green tea polyphenol, as control was 26μM. Furthermore, treatment with geraniin inhibited okadaic acid tumor promotion in a two-stage carcinogenesis experiment on mouse skin. Geraniin and corilagin are present in another well-known Japanese traditional herb, Geranium thunbergii, Genno-shoko in Japanese. Considering seasonal variations of the agents and sites of cultivation of herbs, this paper reviews the significance of geraniin as a new cancer preventive agent. In addition, based on accumulated results of green tea as a cancer preventive, we review two important results with EGCG: the synergistic effects of EGCG with sulindac or tamoxifen on cancer preventive activity in PC-9 cells, and cancer prevention of intestinal tumor development in multiple intestinal neoplasia (Min) mice by cotreatment using EGCG with sulindac. We report here new findings on additional gene expression resulting from cotreatment with EGCG and sulindac in PC-9 cells compared with gene expression by EGCG alone or sulindac alone. Overall, our results indicate that, with the continuing spread of cancer chemoprevention as a fundamental medical strategy, both clinicians and researchers should take a closer look at herbal medicine.

AB - Herbal medicines are now attracting attention as potential sources of cancer preventive agents. Using inhibition of tumor necrosis factor-α (TNF-α) release assay, we studied Acer nikoense, Megusurino-ki in Japanese. Inhibitory potential was found in the leaf extract, and the main active principles were identified as geraniin and corilagin. The IC50 values for TNF-α release inhibition were 43μM for geraniin and 76μM for corilagin, whereas that for (-)-epigallocatechin gallate (EGCG), the green tea polyphenol, as control was 26μM. Furthermore, treatment with geraniin inhibited okadaic acid tumor promotion in a two-stage carcinogenesis experiment on mouse skin. Geraniin and corilagin are present in another well-known Japanese traditional herb, Geranium thunbergii, Genno-shoko in Japanese. Considering seasonal variations of the agents and sites of cultivation of herbs, this paper reviews the significance of geraniin as a new cancer preventive agent. In addition, based on accumulated results of green tea as a cancer preventive, we review two important results with EGCG: the synergistic effects of EGCG with sulindac or tamoxifen on cancer preventive activity in PC-9 cells, and cancer prevention of intestinal tumor development in multiple intestinal neoplasia (Min) mice by cotreatment using EGCG with sulindac. We report here new findings on additional gene expression resulting from cotreatment with EGCG and sulindac in PC-9 cells compared with gene expression by EGCG alone or sulindac alone. Overall, our results indicate that, with the continuing spread of cancer chemoprevention as a fundamental medical strategy, both clinicians and researchers should take a closer look at herbal medicine.

KW - EGCG

KW - Sulindac

KW - Tamoxifen

KW - TNF-α releasing inhibitors

UR - http://www.scopus.com/inward/record.url?scp=0037292963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037292963&partnerID=8YFLogxK

U2 - 10.1016/S0027-5107(02)00327-5

DO - 10.1016/S0027-5107(02)00327-5

M3 - Article

C2 - 12628509

AN - SCOPUS:0037292963

VL - 523-524

SP - 119

EP - 125

JO - Mutation Research

JF - Mutation Research

SN - 0027-5107

ER -